Results 21 to 30 of about 2,320 (120)

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study

Cancer, Volume 131, Issue 17, 1 September 2025.
Abstract Background Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) account for more than 50% of all NENs. The survival of patients with GEP‐NENs has improved based on early diagnosis and improved treatment strategies. The real‐world data of GEP‐NENs in Taiwan are limited.
Hui‐Jen Tsai, Ming‐Huang Chen, Hsiu‐Po Wang, Chin‐Fu Hsiao, Yen‐Yang Chen, Jen‐Shi Chen, Mei‐Due Yang, Chin‐Yuan Tzen, Yan‐Shen Shan, Li‐Yaun Bai, De‐Chuan Chan, Pei‐Yi Chu, Ching‐Liang Ho, Youngsen Yang, Johnson Lin, Hsuan‐Yu Lin, Cheng‐Shyong Chang, Chuan‐Cheng Wang, Tsann‐Long Hwang, Li‐Tzong Chen   +19 more
wiley   +1 more source

Differences in Endoscopic Features of Gastric Neuroendocrine Tumor and Neuroendocrine Carcinoma From a Clinicopathological Perspective

JGH Open, Volume 9, Issue 9, September 2025.
ABSTRACT Gastric neuroendocrine neoplasms are a rare type of stomach cancer, classified into well‐differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Gastric NETs (G‐NETs) originate from endocrine progenitor cells in the basal layer of the mucosa, primarily in the setting of chronic atrophic gastritis,
Katsunori Matsueda, Noriya Uedo, Masanori Kitamura, Seiji Kawano, Motoyuki Otsuka   +4 more
wiley   +1 more source

Cholecystokinin: Clinical aspects of the new biology

Journal of Internal Medicine, Volume 298, Issue 3, Page 251-267, September 2025.
Abstract Cholecystokinin (CCK) is a classic gut hormone that has been known for almost a century to regulate gallbladder emptying, pancreatic enzyme secretion, and gastrointestinal motor activity. In 1968, the CCK structure was identified by Viktor Mutt and Erik Jorpes from porcine gut extracts as a peptide of 33 amino acid residues.
Jens F. Rehfeld
wiley   +1 more source

Type 2 and type 3 gastric neuroendocrine tumors have high risk of lymph node metastasis: Systematic review and meta‐analysis

Digestive Endoscopy, Volume 37, Issue 8, Page 834-843, August 2025.
Objectives Lymph node metastasis (LNM) is crucial in determining treatment strategies for gastric neuroendocrine tumors (gNETs). While type 3 is considered more aggressive than types 1 and 2 within the clinical subtype of gNETs, the supporting data were insufficient, due to their rarity. We aimed to study the prevalence and risk factors associated with
Yohei Ogata, Waku Hatta, Takeshi Kanno, Masahiro Saito, Xiaoyi Jin, Naoki Asano, Tomoyuki Koike, Akira Imatani, Yuhong Yuan, Atsushi Masamune   +9 more
wiley   +1 more source

Prognostic value of clinical parameters and exosomal lncRNA NEAT1_1 in MEN1‐related non‐functioning pancreatic neuroendocrine tumors

Journal of Neuroendocrinology, Volume 37, Issue 8, August 2025.
Abstract Non‐functioning pancreatic neuroendocrine tumors (NF‐pNETs) significantly contribute to the premature death of multiple endocrine neoplasia type 1 (MEN1) patients. Reliable prognostic markers are not yet available. MicroRNAs (miRNA) and long‐non‐coding (lnc) RNAs, transported by extracellular vesicles, are emerging as new prognostic tools ...
Jerena Manoharan, Max Albers, Natalia Khizanishvili, Norman Krasser‐Gercke, Maxime Schmitt, Ioannis Mintziras, Sabine Wächter, Anja Rinke, Yutong Gao, Jörg W. Bartsch, Moritz Jesinghaus, Pietro Di Fazio, Detlef K. Bartsch   +12 more
wiley   +1 more source

Pancreatic neuroendocrine tumors in children and adolescents—Data from the German MET studies (1997–2023)

Journal of Neuroendocrinology, Volume 37, Issue 8, August 2025.
Abstract Pancreatic neuroendocrine tumors (panNETs) are rare pediatric malignancies with age‐specific clinical and biological features. Data on their presentation, management, and outcomes remain limited. This retrospective study analyzed 28 pediatric panNET cases from the German Malignant Endocrine Tumor (MET) Registry enrolled between 1997 and 2024 ...
Katharina Karges, Marina Kunstreich, Ulrich‐Frank Pape, Jörg Fuchs, Christian Vokuhl, Michael Abele, Dominik T. Schneider, Ines B. Brecht, Constantin Lapa, Michael C. Frühwald, Peter Vorwerk, Antje Redlich, Michaela Kuhlen   +12 more
wiley   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

Cancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis, Timothy Kennedy, Sareena Singh, Gerard Abood, Eric Christenson, Christopher J. Anker, Dmitriy Akselrod, Christopher L. Hallemeier, Krishan R. Jethwa, Ed Kim, Percy Lee, Eric D. Miller, Neil B. Newman, J. Eva Selfridge, Navesh Sharma, William Small Jr, Leila Tchelebi, Vonetta M. Williams, Suzanne Russo   +18 more
wiley   +1 more source

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

Clinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Severe esophageal stricture after perforation and necrotizing esophagitis: unusual presentation of a duodenal gastrinoma. [PDF]

J Surg Case Rep, 2023
Ito S, Ogawa R, Komura M, Hayakawa S, Okubo T, Sagawa H, Tanaka T, Mitsui A, Takahashi S, Takiguchi S.   +9 more
europepmc   +1 more source

Gastrin and gastrinomas

Journal of British Surgery, 1990
openaire   +2 more sources